Xarelto vs Ibrance
Side-by-side drug price comparison from Medicare Part D data
Verdict
Xarelto costs 97% less per claim than Ibrance ($321.00 vs $10816.00). Xarelto has a generic alternative available. Total Medicare spending: Xarelto at $5.0B vs Ibrance at $4.5B.
| Metric | Xarelto | Ibrance |
|---|---|---|
| Avg Cost per Claim Average cost Medicare pays per prescription claim | $321* | $10,816 |
| Total Medicare Spending Total Medicare Part D spending on this drug | $5.0B | $4.5B |
| Total Claims | 15,680,000 | 418,000 |
| Year-over-Year Change Price change from prior year (lower is better for patients) | -1.2% | -5.6%* |
| Generic Available | Yes | Yes |
| Condition | Blood Clots | Cancer |
| Total Beneficiaries | 1,920,000 | 36,000 |
Xarelto costs 97% less per claim than Ibrance ($321.00 vs $10816.00). Xarelto has a generic alternative available. Total Medicare spending: Xarelto at $5.0B vs Ibrance at $4.5B.